Loading
institutionsInstitution
Chinese PLA General Hospital
China's military flagship hospital, known in oncology for early CAR-T and gene-edited T-cell trials, minimally invasive liver surgery and nuclear medicine.
Also called: 301 Hospital解放军总医院
Overview
The Chinese PLA General Hospital, commonly called 301 Hospital, is the largest military hospital in China and a comprehensive tertiary centre in Beijing. Its Department of Bio-therapeutics under Weidong Han ran some of the earliest Chinese CAR-T and CRISPR-edited T-cell studies in lymphoma and solid tumours, and its haematology, hepatobiliary surgery (including laparoscopic and robotic hepatectomy), urology and interventional radiology departments are national leaders. The hospital has a large PET/CT and nuclear medicine service and serves as a national referral centre for complex cases from across China.
Location
Beijing, CN
Type
hospital
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#259 · 24 points (0 Newsweek + 0 NCI + 24 from 12 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-24.
Matched to Chinese PLA General Hospital, including child institutions. 1,164 works · 12,024 citations · 77% open access · 11% clinical trials · 2% reviews.
Oncology works per year
2352022
2422023
2512024
2752025
1612026
Most works
- Zefei Jiang39 works
- Rong Liu39 works
- Yi Hu34 works
- Weidong Han30 works
- Jianming Xu20 works
- Guanghai Dai19 works
- Zhikuan Wang18 works
- Haitao Tao17 works
- Qu Liu17 works
- Enqiang Linghu16 works
Most cited
- CAR-T and gene-edited T-cell trials
- Hepatobiliary and robotic surgery
- Nuclear medicine
- Haematology
Similar pages
- CompanyCaribou Biosciences
Shares CRISPR functional genomics, CD19, CAR-T cell therapy, Diffuse large B-cell lymphoma.
- CompanyImugene
Shares CD19, CAR-T cell therapy, Diffuse large B-cell lymphoma.
- InstitutionSiriraj Hospital, Mahidol University
Shares Robotic & minimally invasive surgery, CAR-T cell therapy, Hepatocellular carcinoma, Acute myeloid leukaemia.
- CompanyCellogen Therapeutics
Shares CD19, CAR-T cell therapy, Diffuse large B-cell lymphoma.
- PersonWaseem Qasim
Shares CRISPR functional genomics, CD19, CAR-T cell therapy.
- InstitutionSeoul St. Mary's Hospital
Shares Robotic & minimally invasive surgery, CAR-T cell therapy, Acute myeloid leukaemia, Diffuse large B-cell lymphoma.
- CompanyPoseida Therapeutics
Shares CD19, CAR-T cell therapy, Diffuse large B-cell lymphoma.
- TrialPhase 1/2 Study of CD19 Chimeric Antigen Receptor T-cell (CD19 CAR-T; PL001) for Relapsed or Refractory B-cell Lymphoma
Shares CD19, Diffuse large B-cell lymphoma.